REFERENZE BIBLIOGRAFICHE
Vivekananda MR, Vandana KL, Bhat KG. Effect of the probiotic Lactobacilli reuteri (Prodentis) in the management of periodontal disease: a preliminary randomized clinical trial. Journal of Oral Microbiology, 2010;2:5344.
Indrio F, Riezzo G, Raimondi F, Bisceglia M, Filannino A, Cavallo L, Francavilla
R.
Lactobacillus reuteri accelerates gastric emptying and improves
regurgitation in infants. Eur J Clin Invest, 2010;epub.
Liu Y, Fatheree NY, Mangalat N, Rhoads JM.
Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation.
Am J Physiol Gastrointest Liver Physiol, 2010;299(5):G1087-96.
Savino F, Cordisco L, Tarasco V, Palumeri E, Calabrese R, Oggero R, Roos S,
Matteuzzi D. Lactobacillus reuteri
DSM 17938 in infantile
colic: a randomized, double-blind, placebo-controlled trial.
Pediatrics, 2010;126(3):e526-33.
Romano C, Ferrau' V, Cavataio F, Iacono G, Spina M, Lionetti E, Comisi F, Famiani
A, Comito D.
Lactobacillus reuteri in children with functional abdominal pain (FAP).
J Paediatr Child Health, 2010;epub.
Coccorullo P, Strisciuglio C, Martinelli M, Miele E, Greco L, Staiano A.
Lactobacillus reuteri
(DSM 17938) in Infants
with Functional Chronic Constipation: A Double-Blind, Randomized,
Placebo-Controlled Study. J Pediatr, 2010; 157(4):598-602.
Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, Betta P.
Role of probiotics in the
prevention of the enteric colonization by Candida in preterm newborns: incidence
of late-onset sepsis and neurological outcomes. J Perinat,
2010;epub.
Miniello VL, Brunetti L, Tesse R, Natile M, Armenio L, and Francavilla R.
Lactobacillus Reuteri
Modulates Cytokines Production in Exhaled Breath Condensate of Children With
Atopic Dermatitis. J Ped Gastroenterol Nutr,
2010;50(5):573-6.
Ojetti V, Gigante G, Gabrielli M, Ainora ME, Mannocci A, Lauritano EC, Gasbarrini
G, Gasbarrini A.
The effect of oral supplementation with Lactobacillus reuteri or tilactase in
lactose intolerant patients: randomized trial. Eur Rev Med
Pharmacol Sci, 2010;14(3):163-70.
Egervärn M, Lindmark H, Olsson J, Roos S.
Transferability of a
tetracycline resistance gene from probiotic Lactobacillus reuteri to
bacteria in the gastrointestinal tract of humans. Antonie van
Leeuwenhoek, 2010;97:189-200.
Oh PL, Benson AK, Peterson DA, Patil PB, Moriyama EN, Roos S, Walter J.
Diversification of the gut
symbiont Lactobacillus reuteri as a result of host-driven evolution.
The ISME Journal, 2010; 4(3):377-87
Dommels YE, Kemperman RA, Zebregs YE, Draaisma RB, Jol A, Wolvers DA, Vaughan EE,
Albers R. Survival
of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in
the human gastrointestinal tract with daily consumption of a low-fat probiotic
spread. Appl Environ Microbiol, 2009;75(19):6198-204.
Connolly E. State
of the art on research of Lactobacillus reuteri.
Minerva Pediatrica, 2009;61(6):634-636.
Egervärn M, Roos S, Lindmark H.
Identification and
characterization of antibiotic resistance genes in Lactobacillus reuteri
and Lactobacillus plantarum. J Appl Microbiol,
2009;107:1658–1668.
Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Bjorksten B.
Probiotic lactobacilli in
breast milk and infant stool in relation to oral intake during the first year of
life. J Pediatr Gastroenterol Nutr, 2009; 49(3):349-54.
Ma X, Mao YK, Wang B, Huizinga JD, Bienenstock J, Kunze WA.
Lactobacillus reuteri
ingestion prevents hyperexcitability of colonic DRG neurons induced by
noxious stimuli. Am J Physiol Gastrointest Liver Physiol,
2009 Jan 29.
Schreiber O, Petersson J, Phillipson M, Perry MA, Roos S, Holm L.
Lactobacillus reuteri
prevents colitis by reducing P-selectin-associated leukocyte and
platelet-endothelial cell interactions. Am J Physiol
Gastrointest Liver Physiol, 2009;15.
Jones SE, Versalovic J.
Probiotic
Lactobacillus reuteri biofilms produce antimicrobial and anti-inflammatory
factors. BMC Microbiol, 2009 Feb 11;9(1):35.
Twetman S, Derawi B, Keller M, Ekstrand K, Yucel-Lindberg T, Stecksen-Blicks C.
Short-term effect
of chewing gums containing probiotic Lactobacillus reuteri on the
levels of inflammatory mediators in gingival crevicular fluid.
Acta Odontol Scand, 2009 Feb;67(1):19-24.
Bruni FM, Piacentini GL, Peroni DG, Bodini A, Fasoli E, Boner AL.
Cow's milk allergic
children can present sensitisation to probiotics. Acta Paediatr,
2009 Feb;98(2):321-3.
Karimi K, Inman MD, Bienenstock J, Forsythe P.
Lactobacillus reuteri-induced
regulatory T cells protect against an allergic airway response in mice.
Am J Respir Care Med, 2009;179:186-93.
Iyer C, Kosters A, Sethl G, Kunnumakkara AB, Aggarwal BB, Versalovic J.
Probiotic
Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid
leukemia-derived cells by modulation of NF-KB and MAPK signalling.
Cellular Microbiol, 2008;10:1442-52.
Hüfner E, Britton RA, Roos S, Jonsson H, Hertel C.
Global transcriptional
response of Lactobacillus reuteri to the sourdough environment.
Syst Appl Microbiol, 2008 Oct;31(5):323-38.
Rosander A, Connolly E, Roos S.
Removal of antibiotic resistance gene-carrying
plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the
resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol, 2008
Oct;74(19):6032-40.
Böttcher MF, Abrahamsson TR, Fredriksson M, Jakobsson T, Björkstén B.
Low breast
milk TGF-beta2 is induced by Lactobacillus reuteri supplementation and
associates with reduced risk of sensitization during infancy. Pediatr Allergy
Immunol, 2008 Sep;19(6):497-504.
De Vecchi E, Nicola L, Zanini S, Drago L.
In vitro screening of probiotic
characteristics of some Italian products. J Chemother, 2008 Jun;20(3):341-7.
Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J.
Human-derived probiotic
Lactobacillus reuteri demonstrate antimicrobial
activities targeting diverse enteric bacterial pathogens. Anaerobe, 2008
Jun;14:166-171.
Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R.
The
effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal
motility in preterm newborns. J Pediatr, 2008 Jun;152(6):801-6.
Francavilla R, Lionetti E, Castellaneta SP, Magistà AM, Maurogiovanni G, Bucci N,
De Canio A, Indrio F, Cavallo L, Ierardi E, Miniello VL. Inhibition of
Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and
effect on eradication therapy: a pilot study. Helicobacter, 2008
Apr;13(2):127-34.
Napoleone E, Di Blasio E, Menghi I, Dall’Olio A , Ionata A, Meffe D, Pinti C,
Portolan C. I probiotici nella stipsi funzionale del lattante.
Pediatria
Preventiva e Sociale, 2008;2:7-16 (in Italian).
Whitehead K, Versalovic J, Roos S, Britton RA.
Genomic and genetic
characterization of the bile stress response of probiotic Lactobacillus reuteri
ATCC 55730. Appl Environ Microbiol, 2008 Mar;74(6):1812-9.
Cleusix V, Lacroix C, Vollenweider S, Duboux M, Le Blay G.
Inhibitory activity
spectrum of reuterin produced by Lactobacillus reuteri against intestinal
bacteria. BMC Microbiology, 2007 Nov 12;7:101.
Imase K, Tanaka A, Tokunaga K, Sugano H, Ishida H, Takahashi S.
Lactobacillus
reuteri tablets suppress Helicobacter pylori infection--a double-blind
randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi,
2007 Jul;81(4):387-93.
Wall T, Båth K, Britton RA, Jonsson H, Versalovic J, Roos S.
The early response
to acid shock in Lactobacillus reuteri involves the ClpL chaperone and a
putative cell wall-altering esterase. Appl Environ Microbiol, 2007
Jun;73(12):3924-35.
Arsköld E, Svensson M, Grage H, Roos S, Rådström P, van Niel EW.
Environmental
influences on exopolysaccharide formation in Lactobacillus reuteri ATCC 55730.
Int J Food Microbiol, 2007 May 1;116(1):159-67.
Abrahamsson TR, Jakobsson T, Böttcher MF, Fredrikson M, Jenmalm MC, Björkstén B,
Oldaeus G. Probiotics in prevention of IgE-associated eczema: a double-blind,
randomized, placebo-controlled trial. J Allergy Clin Immunol, 2007
May;119(5):1174-80.
Egervärn M, Danielsen M, Roos S, Lindmark H, Lindgren S.
Antibiotic
susceptibility profiles of Lactobacillus reuteri and Lactobacillus fermentum.
J
Food Prot, 2007 Feb;70(2):412-8.
Savino F, Pelle E, Palumeri E, Oggero R, Miniero R.
Lactobacillus reuteri
(American Type Culture Collection Strain 55730) versus simethicone in the
treatment of infantile colic: a prospective randomized study. Pediatrics, 2007
Jan;119(1):124-30.
Glintborg B, Dawids S, Hasselby JP, Nielsen HW, Nielsen AM. Long term
administration of Lactobacillus reuteri (ATCC 55730) has no influence on gastric
mucosal inflammation and colonization of Helicobacter pylori in humans. A pilot
study. Int J Probiotics Prebiotics, 2006;1:219-24.
Kamiya T, Wang L, Forsythe P, Goettsche G, Mao Y, Wang Y, Tougas G, Bienenstock
J. Inhibitory effects of
Lactobacillus reuteri on visceral pain induced by
colorectal distension in Sprague-Dawley rats. Gut, 2006;55:191-96.
Krasse P, Carlsson B, Dahl C, Paulsson A, Nilsson A, Sinkiewicz G.
Decreased gum
bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swed
Dent J, 2006;30(2):55-60.
Lionetti E, Miniello VL, Castellaneta SP, Magistá AM, de Canio A, Maurogiovanni
G, Ierardi E, Cavallo L, Francavilla R.
Lactobacillus reuteri therapy to reduce
side-effects during anti-Helicobacter pylori treatment in children: a randomized
placebo controlled trial. Aliment Pharmacol Ther, 2006 Nov 15;24(10):1461-8.
Caglar E, Cildir SK, Ergeneli S, Sandalli N, Twetman S. Salivary mutans
streptococci and lactobacilli levels after ingestion of the probiotic bacterium
Lactobacillus reuteri ATCC 55730 by straws or tablets. Acta Odontol Scand, 2006
Oct;64(5):314-8.
Weizman Z, Alsheikh A.
Safety and tolerance of a probiotic formula in early
infancy comparing two probiotic agents: a pilot study. J Am Coll Nutr, 2006
Oct;25(5):415-9.
Kastner S, Perreten V, Bleuler H, Hugenschmidt G, Lacroix C, Meile L.
Antibiotic
susceptibility patterns and resistance genes of starter cultures and probiotic
bacteria used in food. Syst Appl Microbiol, 2006 Mar;29(2):145-55.
Dobrogosz WJ. Enhancement of human health with Lactobacillus reuteri. A
probiotic, immunobiotic and immunoprobiotic. Nutrafoods, 2005;4(2/3):15-28.
Båth K, Roos S, Wall T, Jonsson H.
The cell surface of Lactobacillus reuteri ATCC
55730 highlighted by identification of 126 extracellular proteins from the
genome sequence. FEMS Microbiol Lett, 2005 Dec 1;253(1):75-82.
Tubelius P, Stan V, Zachrisson A.
Increasing work-place healthiness with the
probiotic Lactobacillus reuteri: a randomised, double-blind placebo-controlled
study. Environ Health, 2005 Nov 7;4:25.
Connolly E, Abrahamsson T, Björkstén B.
Safety of D(-)-lactic acid producing
bacteria in the human infant. J Ped Gastr Nutr, 2005;41:489-92.
Weizman Z, Asli G, Alsheikh A.
Effect of a probiotic infant formula on infections
in child care centers: comparison of two probiotic agents. Pediatrics, 2005
Jan;115(1):5-9.
Eom TH, Oh EY, Kim YH, Lee HS, Jang PS, Kim DU, Kim JT, Lee BC. The therapeutic
effect of Lactobacillus reuteri in acute diarrhea in infants and toddlers.
Korean J Pediatr 2005;48:986-90.
Ma D, Forsythe P, Bienenstock J.
Live Lactobacillus reuteri is essential for the
inhibitory effect on tumor necrosis factor alpha-induced interleukin-8
expression. Infect Immun, 2004;72:5308-14.
Connolly E. Lactobacillus reuteri ATCC 55730 – a clinically proven probiotic.
Nutrafoods, 2004;3(1):15-22.
Nikawa H, Makihira S, Fukushima H, Nishimura H, Ozaki Y, Ishida K, Darmawan S,
Hamada T, Hara K, Matsumoto A, Takemoto T, Aimi R.
Lactobacillus reuteri in
bovine milk fermented decreases the oral carriage of mutans streptococci.
Int J
Food Microbiol, 2004 Sep 1;95(2):219-23.
Peña JA, Li SY, Wilson PH, Thibodeau SA, Szary AJ, Versalovic J.
Genotypic and
phenotypic studies of murine intestinal lactobacilli: species differences in
mice with and without colitis. Appl Environ Microbiol, 2004;70:558-68.
Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K.
Colonization and
immunomodulation by Lactobacillus reuteri ATCC 55730 in the human
gastrointestinal tract. Appl Environ Microbiol, 2004 Feb;70(2):1176-81.
Casas IA, Dobrogosz WJ. Validation of the probiotic concept: Lactobacillus
reuteri confers broad spectrum protection against disease in humans and animals.
Microbial Ecology in Health and Disease, 2000;12:247-285.
Wolf BW, Wheeler KB, Ataya DG, Garleb KA.
Safety and tolerance of Lactobacillus
reuteri supplementation to a population infected with the human immunodeficiency
virus. Food Chem Toxicol, 1998 Dec;36(12):1085-94.
Shornikova AV, Casas IA, Mykkänen H, Salo E, Vesikari T.
Bacteriotherapy with
Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J, 1997
Dec;16(12):1103-7.
Shornikova AV, Casas IA, Isolauri E, Mykkänen H, Vesikari T.
Lactobacillus
reuteri as a therapeutic agent in acute diarrhea in young children.
J Pediatr
Gastroenterol Nutr, 1997 Apr;24(4):399-404.
Wolf BW, Garleb K, Ataya, D, Casas IA. Safety and tolerance of Lactobacillus
reuteri in healthy adults male subjects. Microbial Ecology Health Disease,
1995;8:41-50.